Psoriatic arthritis (PsA) affects roughly 30% of patients with psoriasis, yet no 2 cases look alike, says Philip Mease, MD, director of rheumatology and research, Providence Swedish Medical Center, ...

Please provide your email address to receive an email when new articles are posted on . In patients with psoriatic arthritis, secukinumab and adalimumab demonstrated similar results regarding ...

The severity of enthesitis in psoriatic arthritis is a potential marker for severe disease and joint damage, a cross-sectional study found. For instance, a 10-unit increase on the Madrid Sonographic ...

VIENNA — The investigational interleukin (IL)-17 inhibitor izokibep hit its mark when it came to improving overall disease activity in people with active psoriatic arthritis (PsA) in a phase 2b/3 ...

Juvenile idiopathic arthritis (JIA) encompasses a group of pediatric inflammatory arthritides that includes oligoarticular JIA, polyarticular JIA, systemic JIA, psoriatic JIA, and enthesitis-related ...

Please provide your email address to receive an email when new articles are posted on . Ultrasound discriminated between SpA-related enthesitis and other pathologies. Power Doppler signal at enthesis ...

"The contribution of ultrasound to the understanding of the pathophysiology of PsA and improving the accuracy of diagnosis is invaluable." — Ari Polachek, MD, Tel Aviv University PsA commonly ...

Guselkumab shows early and durable improvement in joint symptoms, spinal pain, and skin clearance through 2 years in biologic-naive patients with active psoriatic arthritis (PsA), with a considerable ...